Tweenvest Stocks

BioDlink International Company Limited (SEHK: 1875)

Health Care · Biotechnology · CN

HK$3.56

-4.30% today · +64.1% 1Y

BioDlink International Company Limited (SEHK: 1875) operates in the Biotechnology industry within the Health Care sector. The company is valued at $350.57M and employs 596 people.

Over the last twelve months the share price has gained 64.1%, trading between 1.70 and 5.87.

Tweenvest scores BioDlink International Company Limited across four factors: quality 62/100, value 47/100, growth 100/100. Its strongest factor is growth.

1875 price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$350.57M
Revenue (TTM)
$74.27M
P/E
—
EPS
-0.23
Dividend yield
—
Beta (5Y)
-0.11
52-week high
HK$5.87
52-week low
HK$1.70
Avg volume (3M)
—
Shares outstanding
772.79M
Employees
596
Next earnings
—

About BioDlink International Company Limited

BioDlink International Co., Ltd. operates as a clinical-stage biopharmaceutical firm, dedicating its resources to the development and future commercialization of novel oncology drugs and therapeutic solutions. Its pipeline features several key product candidates, including TAB008, TOZ309, TAA013, TAE020, TAB 014, and TAC020. The company was founded on December 4, 2009, and its primary base of operations is situated in Suzhou, China.

ISIN
HK0000545266
Founded
2009
Listed since
Nov 8, 2019
Exchange
The Stock Exchange of Hong Kong Ltd.
Currency
HKD
CompanyMarket capPriceDay
Emergent BioSolutions Inc.NYSE: EBS$357.89M$6.98-1.13%
Cuorips Inc.TSE: 4894$353.89M¥6,310.00+0.80%
Jiangsu CoWin Biotech Co., Ltd.SHSE: 688426$353.03MCN¥21.51-4.74%
Jiangsu Gdk Biological Technology Co., LtdSHSE: 688670$352.60MCN¥19.17+2.35%
Surrozen, Inc.NasdaqCM: SRZN$348.96M$24.76-16.60%
BioNote, Inc.KOSE: A377740$348.29M₩4,640.00-1.28%
Jiangsu Recbio Technology Co., Ltd.SEHK: 2179$347.01MHK$4.42+0.23%
ROKIT Healthcare Inc.KOSDAQ: A376900$346.80M₩26,850.00-3.24%

Browse every Biotechnology company →

Figures last refreshed Oct 11, 2026.